Evidence map›Paper›PMID 23846481›Full record

ArticleMolecular medicine reports2013

Houttuynia cordata Thunb inhibits the production of pro-inflammatory cytokines through inhibition of the NFκB signaling pathway in HMC-1 human mast cells.

Hee Joe Lee, Hye-Sook Seo, Gyung-Jun Kim, Chan Yong Jeon, Jong Hyeong Park, Bo-Hyoung Jang, Sun-Ju Park, Yong-Cheol Shin, Seong-Gyu Ko

Open access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 43 citations in OpenAlex.

  1. Anti-inflammatory and polarization-modulating effects ofJournal of traditional and complementary medicine · 2026
    Article
  2. Biomedicines · 2026
    Article
  3. Immunomodulatory Effects of Medicinal Plants.Advances in experimental medicine and biology · 2026
    Review
  4. Review
  5. Article
  6. Dentistry journal · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Nutraceutical prospects ofFood bioscience · 2022
    Article
  11. Article
  12. Pharmacological Effects ofPharmaceuticals (Basel, Switzerland) · 2022
    Review
  13. Review
  14. Oral Supplementation ofFrontiers in immunology · 2022
    Article
  15. Article
  16. Review
  17. Article
  18. Frontiers in pharmacology · 2021
    Review
  19. Article
  20. Evidence-based complementary and alternative medicine : eCAM · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Hee Joe LeeDepartment of Oriental Medicine, Kyongwon University, Seongnam, Gyeonggi-Do 461‑701, Republic of Korea.
Hye-Sook Seo
Gyung-Jun Kim
Chan Yong Jeon
Jong Hyeong Park
Bo-Hyoung Jang
Sun-Ju Park
Yong-Cheol Shin
Seong-Gyu Ko
Kyung Hee University · KRKyungdong University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Houttuynia cordata Thunb (HCT) is widely used in oriental medicine as a remedy for inflammation. However, at present there is no explanation for the mechanism by which HCT affects the production of inflammatory cytokines. The current study aimed to determine the effect of an essence extracted from HCT on mast cell-mediated inflammatory responses. Inflammatory cytokine production induced by phorbol myristate acetate (PMA) plus a calcium ionophore, A23187, was measured in the human mast cell line, HMC-1, incubated with various concentrations of HCT. TNF-α, IL-6 and IL-8 secreted protein levels were measured using an ELISA assay. TNF-α, IL-6 and IL-8 mRNA levels were measured using RT-PCR analysis. Nuclear and cytoplasmic proteins were examined by western blot analysis. The NF-κB promoter activity was examined by luciferase assay. It was observed that HCT inhibited PMA plus A23187-induced TNF-α and IL-6 secretion and reduced the mRNA levels of TNF-α, IL-6 and IL-8. It was also noted that HCT suppressed the induction of NF-κB activity, inhibited nuclear translocation of NF-κB and blocked the phosphorylation of IκBα in stimulated HMC-1 cells. It was concluded that HCT is an inhibitor of NF-κB and cytokines blocking mast cell-mediated inflammatory responses. These results indicate that HCT may be used for the treatment of mast cell-derived allergic inflammatory diseases.

Indexed as

CalcimycinCell LineCell SurvivalCytokinesHouttuyniaHumansI-kappa B ProteinsInterleukin-6Interleukin-8Mast CellsNF-kappa BNF-KappaB Inhibitor alphaPhosphorylationPlant ExtractsPromoter Regions, GeneticRNA, MessengerCalcimycinCytokinesI-kappa B ProteinsInterleukin-6Interleukin-8NF-kappa BNF-KappaB Inhibitor alphaNFKBIA protein, humanPlant ExtractsRNA, MessengerTetradecanoylphorbol AcetateTumor Necrosis Factor-alpha

Identifiers

PMID23846481
PMCPMC3782532
OpenAlexW1995666279

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.